MEG3 and growth hormone secreting pituitary adenoma 1: Our observations that MEG3 activation in somatotroph cells due to an activating GNAS mutation, concomitantly the inactivation of Wnt/β-catenin pathway and inhibition of EMT may explain distinctive somatotroph adenoma features.